TY - JOUR
T1 - Implementation strategies for providing optimised tuberculosis and diabetes integrated care in LMICs (POTENTIAL)
T2 - protocol for a multiphase sequential and concurrent mixed-methods study
AU - Afaq, Saima
AU - Zala, Zala
AU - Aleem, Saima
AU - Qazi, Fatima Khalid
AU - Jamal, Syeda Fatima
AU - Khan, Zohaib
AU - Sarfraz, Mariyam
AU - Niazi, Asima Khan
AU - Safdar, Nauman
AU - Basit, Abdul
AU - Ul-Haq, Zia
AU - Iqbal, Romaina
AU - Fatima, Razia
AU - Hewitt, Catherine
AU - Siddiqi, Najma
AU - Parrott, Steve
AU - Siddiqi, Kamran
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2024/11/27
Y1 - 2024/11/27
N2 - INTRODUCTION: Almost a quarter of patients with tuberculosis (TB) in Pakistan may also have diabetes, with an additional quarter in a pre-diabetic state. Diabetes is a risk factor for TB. When it co-occurs with TB, it leads to poorer outcomes for both conditions, considerably increasing the burden on individuals, families and the healthcare system. We aim to improve health, quality of life and economic outcomes for people with TB and diabetes by optimising diabetes prevention, screening and management within TB care. The objectives of this study are to: (1) design an integrated optimised tuberculosis-diabetes care package (Opt-TBD) and its implementation strategies; (2) pilot and refine these implementation strategies and (3) implement and evaluate the Opt-TBD care package in 15 TB care facilities in Pakistan. METHODS AND ANALYSIS: We will work with the TB programme across two provinces of Pakistan: Khyber Pakhtunkhwa and Punjab. TB care facilities will be selected from urban and rural settings of these provinces and will include three levels: primary, secondary and tertiary care settings. This multiphase mixed-method study has three sequential phases. Once ready, the care package and its implementation strategies will be piloted to inform further refinement. The package will be implemented in 15 urban and rural TB care facilities and evaluated for its Reach, Effectiveness, Adoption, Implementation and Maintenance, and potential for scale-up. Quantitative data will assess provider adoption and the package's accessibility and effectiveness for patients with TB and with diabetes and pre-diabetes. Qualitative data will explore barriers and facilitators for successful implementation and scale-up. Data will be analysed using statistical methods-including descriptive and inferential statistics-for quantitative data and framework analysis for qualitative data, with triangulation to integrate findings. ETHICS AND DISSEMINATION: Ethics approval was granted by the National Bioethics Committee of Pakistan (NBCR-1010). Findings will be shared through academic publications, conferences and public outreach.
AB - INTRODUCTION: Almost a quarter of patients with tuberculosis (TB) in Pakistan may also have diabetes, with an additional quarter in a pre-diabetic state. Diabetes is a risk factor for TB. When it co-occurs with TB, it leads to poorer outcomes for both conditions, considerably increasing the burden on individuals, families and the healthcare system. We aim to improve health, quality of life and economic outcomes for people with TB and diabetes by optimising diabetes prevention, screening and management within TB care. The objectives of this study are to: (1) design an integrated optimised tuberculosis-diabetes care package (Opt-TBD) and its implementation strategies; (2) pilot and refine these implementation strategies and (3) implement and evaluate the Opt-TBD care package in 15 TB care facilities in Pakistan. METHODS AND ANALYSIS: We will work with the TB programme across two provinces of Pakistan: Khyber Pakhtunkhwa and Punjab. TB care facilities will be selected from urban and rural settings of these provinces and will include three levels: primary, secondary and tertiary care settings. This multiphase mixed-method study has three sequential phases. Once ready, the care package and its implementation strategies will be piloted to inform further refinement. The package will be implemented in 15 urban and rural TB care facilities and evaluated for its Reach, Effectiveness, Adoption, Implementation and Maintenance, and potential for scale-up. Quantitative data will assess provider adoption and the package's accessibility and effectiveness for patients with TB and with diabetes and pre-diabetes. Qualitative data will explore barriers and facilitators for successful implementation and scale-up. Data will be analysed using statistical methods-including descriptive and inferential statistics-for quantitative data and framework analysis for qualitative data, with triangulation to integrate findings. ETHICS AND DISSEMINATION: Ethics approval was granted by the National Bioethics Committee of Pakistan (NBCR-1010). Findings will be shared through academic publications, conferences and public outreach.
KW - Diabetes Mellitus, Type 2
KW - Implementation Science
KW - Tuberculosis
UR - http://www.scopus.com/inward/record.url?scp=85211220975&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2024-093747
DO - 10.1136/bmjopen-2024-093747
M3 - Article
C2 - 39609009
AN - SCOPUS:85211220975
SN - 2044-6055
VL - 14
SP - e093747
JO - BMJ Open
JF - BMJ Open
IS - 11
ER -